All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-28339094

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	28339094	R122K	S	S	Carcinoma, Hepatocellular	G I C L	View
2	28339094	F183V	S	S	Carcinoma, Hepatocellular	G I C L	View
3	28339094	T140S	S	S	Carcinoma, Hepatocellular	G I C L	View
4	28339094	A194V	S	S	Carcinoma, Hepatocellular	G I C L	View
5	28339094	I126T	S	S	Carcinoma, Hepatocellular	G I C L	View
6	28339094	S3N	S	S	Carcinoma, Hepatocellular	G I C L	View
7	28339094	T68I	S	S	Carcinoma, Hepatocellular	G I C L	View
8	28339094	L269I	RT	P	Carcinoma, Hepatocellular	G C L	View
9	28339094	Q267L	RT	P	Carcinoma, Hepatocellular	G C L	View
10	28339094	N139K	RT	P	Carcinoma, Hepatocellular	G C L	View
11	28339094	Y124H	RT	P	Carcinoma, Hepatocellular	G C L	View
12	28339094	Y124N	RT	P	Carcinoma, Hepatocellular	G C L	View
13	28339094	I91L	RT	P	Carcinoma, Hepatocellular	G C L	View
14	28339094	N238H	RT	P	Carcinoma, Hepatocellular	G C L	View
15	28339094	S53N	RT	P	Carcinoma, Hepatocellular	G C L	View
16	28339094	F221Y	RT	P	Carcinoma, Hepatocellular	G C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.